526 related articles for article (PubMed ID: 20357365)
21. Fibroblast growth factor 21 is required for beneficial effects of exercise during chronic high-fat feeding.
Loyd C; Magrisso IJ; Haas M; Balusu S; Krishna R; Itoh N; Sandoval DA; Perez-Tilve D; Obici S; Habegger KM
J Appl Physiol (1985); 2016 Sep; 121(3):687-98. PubMed ID: 27445299
[TBL] [Abstract][Full Text] [Related]
22. Fibroblast growth factor-21, energy balance and obesity.
Giralt M; Gavaldà-Navarro A; Villarroya F
Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():66-73. PubMed ID: 26415590
[TBL] [Abstract][Full Text] [Related]
23. Robust anti-obesity and metabolic effects of a dual GLP-1/glucagon receptor peptide agonist in rodents and non-human primates.
Henderson SJ; Konkar A; Hornigold DC; Trevaskis JL; Jackson R; Fritsch Fredin M; Jansson-Löfmark R; Naylor J; Rossi A; Bednarek MA; Bhagroo N; Salari H; Will S; Oldham S; Hansen G; Feigh M; Klein T; Grimsby J; Maguire S; Jermutus L; Rondinone CM; Coghlan MP
Diabetes Obes Metab; 2016 Dec; 18(12):1176-1190. PubMed ID: 27377054
[TBL] [Abstract][Full Text] [Related]
24. Interplay between FGF21 and insulin action in the liver regulates metabolism.
Emanuelli B; Vienberg SG; Smyth G; Cheng C; Stanford KI; Arumugam M; Michael MD; Adams AC; Kharitonenkov A; Kahn CR
J Clin Invest; 2014 Feb; 124(2):515-27. PubMed ID: 24401271
[TBL] [Abstract][Full Text] [Related]
25. Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects.
Xu J; Stanislaus S; Chinookoswong N; Lau YY; Hager T; Patel J; Ge H; Weiszmann J; Lu SC; Graham M; Busby J; Hecht R; Li YS; Li Y; Lindberg R; Véniant MM
Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1105-14. PubMed ID: 19706786
[TBL] [Abstract][Full Text] [Related]
26. [Therapeutic effect of fibroblast growth factor 21 on hypertension induced by insulin resistance].
Zhu SL; Ren GP; Zhang ZY; Wang WF; Ye XL; Han MM; Zhao JZ; Xu TY; Liu MY; Li DS
Yao Xue Xue Bao; 2013 Sep; 48(9):1409-14. PubMed ID: 24358774
[TBL] [Abstract][Full Text] [Related]
27. Effect of the slimming agent oleoyl-estrone in liposomes on the body weight of Zucker obese rats.
Balada F; Sanchis D; Grasa MM; Virgili J; Estruch J; Fernández-López JA; Remesar X; Alemany M
Int J Obes Relat Metab Disord; 1997 Sep; 21(9):789-95. PubMed ID: 9376892
[TBL] [Abstract][Full Text] [Related]
28. FGF21 improves glucose homeostasis in an obese diabetes-prone mouse model independent of body fat changes.
Laeger T; Baumeier C; Wilhelmi I; Würfel J; Kamitz A; Schürmann A
Diabetologia; 2017 Nov; 60(11):2274-2284. PubMed ID: 28770320
[TBL] [Abstract][Full Text] [Related]
29. Methionine restriction restores a younger metabolic phenotype in adult mice with alterations in fibroblast growth factor 21.
Lees EK; Król E; Grant L; Shearer K; Wyse C; Moncur E; Bykowska AS; Mody N; Gettys TW; Delibegovic M
Aging Cell; 2014 Oct; 13(5):817-27. PubMed ID: 24935677
[TBL] [Abstract][Full Text] [Related]
30. FGF21 is required for the metabolic benefits of IKKε/TBK1 inhibition.
Reilly SM; Abu-Odeh M; Ameka M; DeLuca JH; Naber MC; Dadpey B; Ebadat N; Gomez AV; Peng X; Poirier B; Walk E; Potthoff MJ; Saltiel AR
J Clin Invest; 2021 May; 131(10):. PubMed ID: 33822771
[TBL] [Abstract][Full Text] [Related]
31. Suppression of hyperinsulinemia restores growth hormone secretion and metabolism in obese mice.
Huang Z; Lu X; Huang L; Chen Y; Zhang C; Veldhuis JD; Chen C
J Endocrinol; 2021 Jul; 250(3):105-116. PubMed ID: 34156345
[TBL] [Abstract][Full Text] [Related]
32. Dietary carbohydrates impair the protective effect of protein restriction against diabetes in NZO mice used as a model of type 2 diabetes.
Laeger T; Castaño-Martinez T; Werno MW; Japtok L; Baumeier C; Jonas W; Kleuser B; Schürmann A
Diabetologia; 2018 Jun; 61(6):1459-1469. PubMed ID: 29550873
[TBL] [Abstract][Full Text] [Related]
33. Long-term characterization of the diet-induced obese and diet-resistant rat model: a polygenetic rat model mimicking the human obesity syndrome.
Madsen AN; Hansen G; Paulsen SJ; Lykkegaard K; Tang-Christensen M; Hansen HS; Levin BE; Larsen PJ; Knudsen LB; Fosgerau K; Vrang N
J Endocrinol; 2010 Sep; 206(3):287-96. PubMed ID: 20508079
[TBL] [Abstract][Full Text] [Related]
34. Influence of food texture on energy metabolism and adiposity in male rats.
Han W; Utoyoma M; Akieda-Asai S; Hidaka A; Yamada C; Hasegawa K; Nunoi H; Date Y
Exp Physiol; 2018 Oct; 103(10):1347-1356. PubMed ID: 30105882
[TBL] [Abstract][Full Text] [Related]
35. Mediterranean Tomato-Based Sofrito Sauce Improves Fibroblast Growth Factor 21 (FGF21) Signaling in White Adipose Tissue of Obese ZUCKER Rats.
Sandoval V; Rodríguez-Rodríguez R; Martínez-Garza Ú; Rosell-Cardona C; Lamuela-Raventós RM; Marrero PF; Haro D; Relat J
Mol Nutr Food Res; 2018 Feb; 62(4):. PubMed ID: 29266852
[TBL] [Abstract][Full Text] [Related]
36. Augmenting leptin circadian rhythm following a weight reduction in diet-induced obese rats: short- and long-term effects.
Buison A; Pellizzon M; Ordiz F; Jen KL
Metabolism; 2004 Jun; 53(6):782-9. PubMed ID: 15164329
[TBL] [Abstract][Full Text] [Related]
37. Fibroblast growth factor 21: effects on carbohydrate and lipid metabolism in health and disease.
Kralisch S; Fasshauer M
Curr Opin Clin Nutr Metab Care; 2011 Jul; 14(4):354-9. PubMed ID: 21505329
[TBL] [Abstract][Full Text] [Related]
38. Increased responses to the actions of fibroblast growth factor 21 on energy balance and body weight in a seasonal model of adiposity.
Murphy M; Samms R; Warner A; Bolborea M; Barrett P; Fowler MJ; Brameld JM; Tsintzas K; Kharitonenkov A; Adams AC; Coskun T; Ebling FJ
J Neuroendocrinol; 2013 Feb; 25(2):180-9. PubMed ID: 22958332
[TBL] [Abstract][Full Text] [Related]
39. A thyroid hormone challenge in hypothyroid rats identifies T3 regulated genes in the hypothalamus and in models with altered energy balance and glucose homeostasis.
Herwig A; Campbell G; Mayer CD; Boelen A; Anderson RA; Ross AW; Mercer JG; Barrett P
Thyroid; 2014 Nov; 24(11):1575-93. PubMed ID: 25087834
[TBL] [Abstract][Full Text] [Related]
40. Anti-obesity effects of KR-66195, a synthetic DPP-IV inhibitor, in diet-induced obese mice and obese-diabetic ob/ob mice.
Lee EY; Kim YW; Oh H; Choi CS; Ahn JH; Lee BW; Kang ES; Cha BS; Lee HC
Metabolism; 2014 Jun; 63(6):793-9. PubMed ID: 24684824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
